YOLFTbeta
InspireMD Inc

InspireMD Inc

NSPR · NASDAQ · Healthcare / Medical Devices

0.64USD-0.13 (-17.31%)

Price History

Full chart

Market Stats

Previous Close0.774
Open0.60
Day Range0.45 – 0.66
52-Week Range0.63 – 2.57
Volume1.30M
Market Cap32.30M
P/E (TTM)0.00
Forward P/E11.70
EPS-0.61
Dividend Yield0.00%
Beta0.82
50-Day Avg0.7876
200-Day Avg1.24

About

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Marvin L. Slosman
  • Employees127
  • Headquarters6303 Waterford District Drive, Miami, FL, United States, 33126, USA
  • Websitehttps://www.inspiremd.com

Leadership

  • Mr. Marvin L. SlosmanPresident, CEO & Director · b. 1964
  • Mr. Michael A. LawlessCFO, Secretary & Treasurer · b. 1969
  • Dr. Peter A. Soukas M.D.Chief Medical Officer

Financials

Income Statement

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-06-302012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.41M-4.95M5.35M5.35M5.35M4.87M2.82M2.31M1.89M2.76M3.60M3.72M2.48M4.50M5.17M6.21M7.01M8.98M
Growth (%)---+8.06%0.00%0.00%-8.90%-42.17%-18.03%-18.01%+45.78%+30.42%+3.33%-33.22%+80.89%+15.04%+20.00%+12.96%+28.11%
Cost of Revenue--2.70M2.85M2.73M2.85M2.28M2.03M2.61M1.79M2.18M2.61M2.96M2.40M3.74M4.05M4.40M5.50M6.33M
Gross Profit--2.25M2.50M2.62M2.50M2.59M784.00K-296.00K102.00K585.00K995.00K756.00K83.00K754.00K1.12M1.81M1.51M2.65M
Gross Margin--45.45%46.74%48.98%46.74%53.15%27.82%-12.81%5.39%21.19%27.63%20.32%3.34%16.77%21.60%29.12%21.49%29.50%
Operating Expense--2.27M20.05M-20.05M17.66M24.48M14.19M7.75M8.82M8.61M10.57M10.46M15.47M19.83M22.95M35.01M51.76M
Operating Income-3.83K-15.48K-15.48K-17.55M--17.55M-15.07M-23.70M-14.48M-7.65M-8.23M-7.61M-9.82M-10.38M-14.72M-18.71M-21.14M-33.50M-49.11M
Operating Margin-0.11%--0.31%-328.01%--328.01%-309.32%-840.95%-627.06%-403.80%-298.15%-211.36%-263.80%-417.71%-327.39%-361.88%-340.74%-478.00%-546.97%
EBITDA-3.83K-6.98K-3.18M-16.23M--16.23M-14.87M-23.43M-14.24M-7.46M-8.05M-7.46M-9.66M-10.23M-14.55M-18.52M-19.62M-31.67M-48.25M
EBITDA Margin-0.11%--64.18%-303.33%--303.33%-305.05%-831.62%-616.62%-393.72%-291.71%-207.14%-259.55%-411.63%-323.80%-358.25%-316.18%-451.79%-537.33%
Net Income-3.83K-23.98K-23.98K-17.60M--17.60M-29.26M-25.09M-15.59M-8.46M-8.44M-7.24M-10.04M-10.54M-14.92M-18.49M-19.92M-32.01M-48.79M
Net Income Margin-0.11%--0.48%-328.98%--328.98%-600.41%-890.53%-674.68%-446.73%-305.61%-201.06%-269.82%-424.31%-331.88%-357.59%-320.97%-456.63%-543.33%
R&D--1.34M3.99M3.99M3.99M4.16M8.74M3.64M1.29M1.28M1.53M2.95M2.23M5.16M7.81M7.98M13.63M15.00M
R&D as % of Total Revenue--27.07%74.56%74.56%74.56%85.29%310.29%157.66%68.16%46.22%42.63%79.39%89.86%114.75%151.03%128.62%194.52%167.09%
Interest Expense3.83K015.48K1.24M01.24M13.60M1.39M1.04M812.00K179.00K042.00K160.00K157.00K28.00K---
Interest Expense % of Total Revenue0.11%-0.31%23.14%0.00%23.14%279.05%49.15%44.85%42.87%6.48%0.00%1.13%6.44%3.49%0.54%---

Balance Sheet

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-06-302012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.92K5.94K5.94K16.01M16.01M16.01M20.75M11.46M5.78M9.41M6.11M12.29M9.88M17.78M39.71M24.65M47.64M46.81M69.40M
Total Liabilities3.25K8.24K8.24K10.63M10.63M10.63M15.33M14.25M8.72M5.37M3.38M3.52M4.50M5.61M6.18M7.26M8.14M10.72M14.20M
Total Equity1.68K-2.30K-2.30K5.39M5.38M5.39M8.64M-2.79M-2.95M4.04M2.73M8.76M5.38M12.16M33.53M17.39M39.50M36.09M55.20M
Cash4.92K5.94K5.94K10.28M10.28M10.28M17.54M6.30M3.26M7.52M3.71M9.38M5.51M12.64M12.00M4.63M9.64M18.92M8.94M
Total Debt--1.14M5.02M5.02M5.02M9.77M8.89M5.33M2.68M--1.01M1.40M1.20M1.61M1.59M2.34M3.29M
Net Debt-4.92K-5.94K-5.94K-5.27M--5.27M-7.76M2.60M2.08M-4.84M-3.71M-9.38M-4.50M-11.25M-10.80M-3.02M-9.64M-16.58M-5.65M

Cash Flow

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-825-18.98K-18.98K-8.58M-8.58M-10.30M-19.36M-11.60M-7.50M-8.13M-7.61M-9.81M-9.08M-13.21M-15.54M-16.38M-21.87M-35.10M
Investing Cash Flow----43.00K0-376.00K-86.00K-23.00K70.00K-318.00K-44.00K-387.00K-187.00K-22.46M8.44M-16.09M12.64M-30.56M
Financing Cash Flow-20.00K20.00K11.07M11.07M15.12M8.27M8.62M11.70M4.63M13.37M6.33M16.39M35.03M-140.00K37.53M18.45M55.57M
Capital Expenditure0080.00K290.00K290.00K202.00K133.00K16.00K49.00K258.00K67.00K284.00K88.00K344.00K473.00K381.00K1.40M1.66M
Free Cash Flow-825-18.98K-18.98K-8.87M-8.87M-10.50M-19.50M-11.61M-7.54M-8.39M-7.67M-10.09M-9.17M-13.55M-16.02M-16.76M-23.27M-36.77M
Dividends Paid---00-0000--------
FCF to OCF100.00%100.00%100.00%103.38%103.38%101.96%100.69%100.14%100.65%103.17%100.88%102.90%100.97%102.60%103.04%102.33%106.41%104.73%
Dividend Paid to FCF---0.00%0.00%-0.00%0.00%0.00%0.00%--------

Earnings

Report DateJun 1, 2011Aug 31, 2011Nov 15, 2011Mar 6, 2012May 8, 2012Sep 12, 2012Nov 2, 2012Feb 27, 2013May 8, 2013Sep 17, 2013Nov 11, 2013Feb 26, 2014May 7, 2014Jul 23, 2014Nov 12, 2014Mar 12, 2015May 11, 2015Aug 5, 2015Nov 10, 2015Mar 28, 2016May 10, 2016Aug 9, 2016Nov 14, 2016Feb 16, 2017May 9, 2017Aug 8, 2017Nov 7, 2017Feb 13, 2018May 7, 2018Aug 6, 2018Nov 6, 2018Feb 19, 2019May 13, 2019Aug 6, 2019Nov 12, 2019Mar 10, 2020May 11, 2020Aug 5, 2020Nov 9, 2020Mar 8, 2021May 10, 2021Aug 9, 2021Nov 8, 2021Mar 7, 2022May 9, 2022Aug 8, 2022Nov 7, 2022Mar 30, 2023May 15, 2023Aug 7, 2023Nov 6, 2023Mar 5, 2024May 13, 2024Aug 5, 2024Nov 12, 2024Mar 12, 2025May 12, 2025Aug 4, 2025Nov 4, 2025Mar 18, 2026May 5, 2026Aug 14, 2026Nov 3, 2026
EPS Estimate---787500.758750.00-525000.50-1000000.00-105000.00--1000000.00-54687.50-48125.00-48125.00-984375.93-1000000.00-1000000.00-1000000.00-21875.00-328125.31-328125.31-20125.00-229687.72-111562.61-----59062.56---148.75-148.75--37.50-30.00-20.25-8.55-9.45-5.25-2.70-0.97-0.60-9.45-0.82-0.78-0.80-0.73-0.73-0.84-0.68-0.30-0.15-0.19-0.15-0.19-0.20-0.20-0.20-0.26-0.19-0.19-0.18-0.20-0.15
EPS Actual-326409.55-925443.12-1000000.00-227500.00-1000000.00-1000000.00-192500.00-710747.84-1000000.00-43750.00-39375.00-56875.00-984381.15-1000000.00-1000000.00-590628.69-39375.00-262501.64-236249.93-16187.50-150937.45-124687.46-1505.00-1531.72-0.65-0.21-4987.50-7.38-1.08-7.50-2.50-5.00-57.30-23.85-18.90-8.55-6.45-3.00-0.90-1.20-0.53-0.46-0.53-0.53-0.57-0.59-0.58-0.60-0.53-0.24-0.15-0.16-0.21-0.22-0.16-0.19-0.22-0.26-0.17-0.14-0.16-0.17-
Surprise---26.98%-2700.00%-90.48%0.00%-83.33%-0.00%20.00%18.18%-18.18%-0.00%0.00%0.00%40.94%-80.00%20.00%28.00%19.57%34.29%-11.76%----91.56%--94.96%98.32%--52.80%20.50%6.67%0.00%31.75%42.86%66.67%-23.71%11.67%95.13%35.37%32.05%28.75%19.18%20.55%28.57%22.06%20.00%0.00%15.79%-40.00%-15.79%20.00%5.00%-10.00%0.00%10.53%26.32%11.11%15.00%-
Timing--Pre-market-Pre-marketPre-market--Pre-market---After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hours-

Key Statistics & Ratios

Market Cap32.30M
Enterprise Value7.78M
Trailing P/E0.00
Forward P/E11.70
PEG Ratio0.00
Price / Sales2.98
Price / Book1.12
EPS-0.61
Book Value0.672
Revenue (TTM)10.84M
Gross Profit (TTM)1.96M
EBITDA-52.98M
Profit Margin0.00%
Operating Margin-815.64%
Return on Equity-202.81%
Return on Assets-85.85%
Shares Outstanding46.84M
Shares Float28.72M
Beta0.82
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 3.33
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
46.31%
Insiders
19.98%
Retail / Other
33.71%

Top Institutional Holders

  • Rosalind Advisors, Inc.
    3.91M8.32%
  • Aberdeen Group PLC
    3.70M7.88%
  • Nantahala Capital Management, LLC
    3.38M7.20%
  • Orbimed Advisors LLC
    3.13M6.68%
  • Parkman Healthcare Partners LLC
    2.42M5.15%
  • Marshall Wace Asset Management Ltd
    1.86M3.96%
  • Soleus Capital Management, L.P.
    1.05M2.23%
  • PURA VIDA INVESTMENTS, LLC
    450.52K0.96%
  • Ingalls & Snyder LLC
    379.30K0.81%
  • Affiance Financial LLC
    250.37K0.53%
  • Velan Capital Investment Management LP
    148.14K0.32%
  • BlackRock Inc
    80.45K0.17%
  • Morgan Stanley - Brokerage Accounts
    39.84K0.08%
  • Millennium Management LLC
    37.68K0.08%
  • Northern Trust Corp
    33.57K0.07%
  • Courier Capital Corp
    30.00K0.06%

Top Fund Holders

  • abrdn Healthcare Investors
    1.74M3.72%
  • abrdn Healthcare Opportunities
    1.26M2.68%
  • abrdn World Healthcare
    695.46K1.48%
  • iShares Micro-Cap ETF
    114.08K0.24%

Stock Splits

  • Apr 27, 20211:15
  • Apr 1, 20191:50
  • Feb 8, 20181:35
  • Oct 10, 20161:25
  • Oct 1, 20151:10
  • Dec 21, 20121:4
  • Apr 11, 2011959692:319897